Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma

Oncology Reports

Volumn 7, Issue 4, 2000, Pages 871-874

  Inoue, Hiroshi ^a   Mimori, Koshi ^a   Shiraishi, Takeshi ^a   Kataoka, Akemi ^a   Sadanaga, Noriaki ^a   Ueo, Hiroaki ^b   Barnard, Graham F ^c   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Breast carcinoma; Invasion; Lymph node metastasis; Matrix metalloproteinase; Tissue inhibitor of metalloproteinase

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; CANCER STAGING; CELL CULTURE; FEMALE; FOLLOW UP; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034222534     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.4.871     Document Type: Article

References (23)

1. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J and Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7: 77-83, 1992.
2. Miyagi E, Yasumitsu H, Hirahara F, Minaguchi H, Koshikawa N, Miyazaki K and Umeda M: Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells. Jpn J Cancer Res 86: 568-576, 1995.
3. Belloc C, Lu H, Soria C, Fridman R, Legrand Y and Menashi S: The effect of platelets on invasiveness and protease production of human mammary tumor cells. Int J Cancer 60: 413-417, 1995.
4. Azuma M, Tamatani T, Fukui K, Yoshida H, Kamogashira T, Ogino K, Suzuki T and Sato M: Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells. Int J Cancer 54: 669-676, 1993.
5. Khokha R and Denharda D: On the use of anti-sense RNA: down-regulation of mRNA encoding a metalloproteinase inhibitor. Anticancer Res 7: 653-660, 1987.
6. Hayakawa T, Yamashita K, Kishi J and Harigaya K: Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM102 has erythroid-potentiating activity, suggesting its possible bifunctional role in the hematopoietic microenvironment. FEBS Lett 268: 125-128, 1990.
7. Bertaux B, Hornebeck W, Eisen AZ and Dubertret L: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97: 679-685, 1991.
8. Agrez MV, Meldrum CJ, Sim AT, Aebersold RH, Clark IM, Cawston TE and Burns GF: A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1. Biochem Biophys Res Commun 206: 590-600, 1995.
9. Zeng Z-S, Cohen AM, Zahng Z-F, Stetler-Stevenson W and Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastasis. Clin Cancer Res 1: 899-906, 1995.
10. Urbanski SJ, Edwards DR, Hershfield N, Huchcroft SA, Shaffer E, Sutherland L and Kossakowska AE: Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasm. Diagn Mol Pathol 2: 81-89, 1993.
11. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr and Chen LB: Significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 105: 820-826, 1993.
12. Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD Jr and Chen LB: Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 8: 2821-2826, 1993.
13. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162: 156-159, 1987.
14. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H and Akiyoshi T: Detection of cancer micrometastasis in lymph nodes by reverse transcription-polymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
15. Mori M, Mimori k, Ueo H, Karimine N, Barnard GF, Sugimachi K and Akiyoshi T: Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 68: 739-743, 1996.
16. Mimori K, Mori M, Shiraishi T, Fujie T, Baba K, Haraguchi M, Abe R, Ueo H and Akiyoshi T: Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 76: 531-536, 1997.
17. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E and Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298: 29-32, 1992.
18. Docherty A, Lyons A, Smith B, Wright E, Stephens P, Harris T, Murphy G and Reynolds J: Sequence of human tissue inhibitor of metalloproteinase and its identity to erythroid-potentiating activity. Nature 318: 66-69, 1985.
19. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T and Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 53: 1397-1402, 1993.
20. Khokha R, Zimmer M, Graham C, Lala P and Waterhouse P: Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84: 1017-1022, 1992.
21. Mohanam S, Wang SW, Rayford A, Yamamoto M, Sawaya R, Nakajima M, Liotta LA, Nicolson GL, Stettier-Stevenson W and Rao JS: Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis 13: 57-62, 1995.
22. Stierer M, Rosen H, Weber R, Hanak H, Spona J and Tuchler H: Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg 218: 13-21, 1993.
23. Tsangaris TN, Knox SM and Cheek JH: Tumor hormone receptor status and recurrences in premenopausal patients with node-negative breast carcinoma; Cancer 69: 984-987, 1992.